These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6613522)

  • 1. 3 years of continuous oral zinc therapy in 4 patients with Wilson's disease.
    Hoogenraad TU; Van den Hamer CJ
    Acta Neurol Scand; 1983 Jun; 67(6):356-64. PubMed ID: 6613522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral zinc as initial therapy in Wilson's disease: two years of continuous treatment in a 10-year-old child.
    Milanino R; Deganello A; Marrella M; Michielutti F; Moretti U; Pasqualicchio M; Tamassia G; Tatò L; Velo GP
    Acta Paediatr; 1992 Feb; 81(2):163-6. PubMed ID: 1515762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral zinc sulphate as long-term treatment in Wilson's disease (hepatolenticular degeneration).
    Hoogenraad TU; Koevoet R; de Ruyter Korver EG
    Eur Neurol; 1979; 18(3):205-11. PubMed ID: 477692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral zinc sulphate for Wilson's disease.
    Van Caillie-Bertrand M; Degenhart HJ; Visser HK; Sinaasappel M; Bouquet J
    Arch Dis Child; 1985 Jul; 60(7):656-9. PubMed ID: 4026362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective treatment of Wilson's disease with oral zinc sulphate: two case reports.
    Hoogenraad TU; Van den Hamer CJ; Van Hattum J
    Br Med J (Clin Res Ed); 1984 Aug; 289(6440):273-6. PubMed ID: 6430436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two and half years of oral zinc sulphate therapy in an adult patient with Wilson's disease.
    Pasqualicchio M; Milanino R; Marrella M; Moretti U; Tomelleri G; Velo GP
    Pharmacol Res; 1989; 21 Suppl 1():151-2. PubMed ID: 2633173
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of Wilson's disease with Zincteral].
    Kuczyńska-Zardzewiały A; Rodo M; Członkowska A
    Neurol Neurochir Pol; 1988; 22(3):211-5. PubMed ID: 3221958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose zinc therapy for maintenance treatment of Wilson's disease.
    Mayet IY
    Clin Pharm; 1990 Dec; 9(12):951-3. PubMed ID: 2292179
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of Wilson's disease with zinc. II. Validation of oral 64copper with copper balance.
    Hill GM; Brewer GJ; Juni JE; Prasad AS; Dick RD
    Am J Med Sci; 1986 Dec; 292(6):344-9. PubMed ID: 3799705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilson's disease: current status.
    Yarze JC; Martin P; Muñoz SJ; Friedman LS
    Am J Med; 1992 Jun; 92(6):643-54. PubMed ID: 1605146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc sulphate therapy for Wilson's disease after acute deterioration during treatment with low-dose D-penicillamine.
    Veen C; van den Hamer CJ; de Leeuw PW
    J Intern Med; 1991 Jun; 229(6):549-52. PubMed ID: 2045766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral zinc in Wilson disease--an alternative to D-penicillamine].
    Ramadori G; Keidl E; Hütteroth T; Dormeyer HH; Manns M; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1985 Jan; 23(1):25-9. PubMed ID: 4060799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Wilson's disease with zinc. I. Oral zinc therapy regimens.
    Hill GM; Brewer GJ; Prasad AS; Hydrick CR; Hartmann DE
    Hepatology; 1987; 7(3):522-8. PubMed ID: 3570163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
    Hoogenraad TU
    Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dangers of interrupting decoppering treatment in Wilson's disease.
    Hoogenraad TU
    Arch Neurol; 1994 Oct; 51(10):972-3. PubMed ID: 7945006
    [No Abstract]   [Full Text] [Related]  

  • 16. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
    Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of action of triethylenetetramine dihydrochloride on copper metabolism in Wilson's disease.
    Siegemund R; Lössner J; Günther K; Kühn HJ; Bachmann H
    Acta Neurol Scand; 1991 Jun; 83(6):364-6. PubMed ID: 1887758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful long term oral zinc in florid Wilson's disease: a case report.
    Kaur U; Bambery P; Bhushnurmath SR; Deodhar SD; Dilawari JB
    Trop Geogr Med; 1988 Apr; 40(2):161-5. PubMed ID: 3407008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc therapy as the initial treatment for Wilson's disease.
    Hoogenraad TU; Van Hattum J
    Arch Neurol; 1988 Apr; 45(4):373-4. PubMed ID: 3355392
    [No Abstract]   [Full Text] [Related]  

  • 20. [Control of the therapeutic prevention of copper uptake in the liver in Wilson's disease following oral administration of 64Cu].
    Günther K; Siegemund R; Lössner J; Kühn HJ
    Radiobiol Radiother (Berl); 1988; 29(2):226-9. PubMed ID: 3399664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.